A revealing new study shows that many abortion pill distributors are flouting regulations in how they dispense harmful Mifepristone to women. The study, released last week by the Charlotte Lozier Institute (CLI), found that 64 drug sellers (81 percent of online vendors) are willing to dispense Mifepristone to women beyond the FDA’s 10-week gestational limit for the drug. The report also noted that 10 companies are violating federal law by sellin…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.